|
1
|
Hébuterne X, Lemarié E, Michallet M, de
Montreuil CB, Schneider SM and Goldwasser F: Prevalence of
malnutrition and current use of nutrition support in patients with
cancer. JPEN J Parenter Enteral Nutr. 38:196–204. 2014. View Article : Google Scholar
|
|
2
|
Ryan AM, Prado CM, Sullivan ES, Power DG
and Daly LE: Effects of weight loss and sarcopenia on response to
chemotherapy, quality of life, and survival. Nutrition. 67–68.
1105392019.
|
|
3
|
Arends J, Baracos V, Bertz H, Bozzetti F,
Calder PC, Deutz NEP, Erickson N, Laviano A, Lisanti MP, Lobo DN,
et al: ESPEN expert group recommendations for action against
cancer-related malnutrition. Clin Nutr. 36:1187–1196. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu J, Huang C, Xiao H, Tang Q and Cai W:
Weight loss and resting energy expenditure in male patients with
newly diagnosed esophageal cancer. Nutrition. 29:1310–1314. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li G, Zhang K, Gong F and Jin H: A study
on changes and clinical significance of blood glucose, blood lipid
and inflammation in patients with ovarian cancer. J BUON.
24:2322–2326. 2019.PubMed/NCBI
|
|
6
|
So AR, Si JM, Lopez D and Pellegrini M:
Molecular signatures for inflammation vary across cancer types and
correlate significantly with tumor stage, sex and vital status of
patients. PLoS One. 15:e02215452020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sakamoto K, Arakawa H, Mita S, Ishiko T,
Ikei S, Egami H, Hisano S and Ogawa M: Elevation of circulating
interleukin 6 after surgery: Factors influencing the serum level.
Cytokine. 6:181–186. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carson JA and Baltgalvis KA: Interleukin 6
as a key regulator of muscle mass during cachexia. Exerc Sport Sci
Rev. 38:168–176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Banks WA: Anorectic effects of circulating
cytokines: Role of the vascular blood-brain barrier. Nutrition.
17:434–437. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tisdale MJ: Mechanisms of cancer cachexia.
Physiol Rev. 89:381–410. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Suzuki H, Asakawa A, Amitani H, Nakamura N
and Inui A: Cancer cachexia-pathophysiology and management. J
Gastroenterol. 48:574–594. 2013. View Article : Google Scholar
|
|
12
|
Bosaeus I: Nutritional support in
multimodal therapy for cancer cachexia. Support Care Cancer.
16:447–451. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Forrest LM, McMillan DC, McArdle CS,
Angerson WJ and Dunlop DJ: Evaluation of cumulative prognostic
scores based on the systemic inflammatory response in patients with
inoperable non-small-cell lung cancer. Br J Cancer. 89:1028–1030.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koike Y, Miki C, Okugawa Y, Yokoe T,
Toiyama Y, Tanaka K, Inoue Y and Kusunoki M: Preoperative
C-reactive protein as a prognostic and therapeutic marker for
colorectal cancer. J Surg Oncol. 98:540–544. 2008. View Article : Google Scholar
|
|
15
|
Gorjao R, Dos Santos CM, Serdan TD, Diniz
VL, Alba-Loureiro TC, Cury-Boaventura MF, Hatanaka E, Levada-Pires
AC, Sato FT, Pithon-Curi TC, et al: New insights on the regulation
of cancer cachexia by N-3 polyunsaturated fatty acids. Pharmacol
Ther. 196:117–134. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Duvall MG and Levy BD: DHA- and
EPA-derived resolvins, protectins, and maresins in airway
inflammation. Eur J Pharmacol. 785:144–155. 2016. View Article : Google Scholar
|
|
17
|
Wang H, Li TL, Hsia S, Su IL, Chan YL and
Wu CJ: Skeletal muscle atrophy is attenuated in tumor-bearing mice
under chemotherapy by treatment with fish oil and selenium.
Oncotarget. 6:7758–7773. 2015. View Article : Google Scholar
|
|
18
|
Whitehouse AS, Smith HJ, Drake JL and
Tisdale MJ: Mechanism of attenuation of skeletal muscle protein
catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Res.
61:3604–3609. 2001.PubMed/NCBI
|
|
19
|
Flock MR, Harris WS and Kris-Etherton PM:
Long-chain omega-3 fatty acids: Time to establish a dietary
reference intake. Nutr Rev. 71:692–707. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mocellin MC, Fernandes R, Chagas TR and
Trindade E: A meta-analysis of n-3 polyunsaturated fatty acids
effects on circulating acute-phase protein and cytokines in gastric
cancer. Clin Nutr. 37:840–850. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mocellin MC, Pastore e Silva Jde A,
Camargo Cde Q, Fabre ME, Gevaerd S, Naliwaiko K, Moreno YM, Nunes
EA and Trindade EB: Fish oil decreases C-reactive protein/albumin
ratio improving nutritional prognosis and plasma fatty acid profile
in colorectal cancer patients. Lipids. 48:879–888. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shirai Y, Okugawa Y, Hishida A, Ogawa A,
Okamoto K, Shintani M, Morimoto Y, Nishikawa R, Yokoe T, Tanaka K,
et al: Fish oil-enriched nutrition combined with systemic
chemotherapy for gastrointestinal cancer patients with cancer
cachexia. Sci Rep. 7:48262017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aoyama T, Yoshikawa T, Ida S, Cho H,
Sakamaki K, Ito Y, Fujitani K, Takiguchi N, Kawashima Y, Nishikawa
K, et al: Effects of perioperative Eicosapentaenoic acid-enriched
oral nutritional supplement on lean body mass after total
gastrectomy for gastric cancer. J Cancer. 10:1070–1076. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mocellin MC, Camargo CQ, Nunes EA, Fiates
GMR and Trindade EBSM: A systematic review and meta-analysis of the
n-3 polyunsaturated fatty acids effects on inflammatory markers in
colorectal cancer. Clin Nutr. 35:359–369. 2013. View Article : Google Scholar
|
|
25
|
Póvoa P, Coelho L, Almeida E, Fernandes A,
Mealha R, Moreira P and Sabino H: C-reactive protein as a marker of
infection in critically ill patients. Clin Microbiol Infect.
11:101–108. 2005. View Article : Google Scholar
|
|
26
|
Sproston NR and Ashworth JJ: Role of
C-reactive protein at sites of inflammation and infection. Front
Immunol. 9:7542018. View Article : Google Scholar
|
|
27
|
Tutino V, De Nunzio V, Caruso MG, Veronese
N, Lorusso D, Masi MD, Benedetto ML and Notarnicola M: Elevated
AA/EPA ratio represents an inflammatory biomarker in tumor tissue
of metastatic colorectal cancer patients. Int J Mol Sci.
20:20502019. View Article : Google Scholar
|
|
28
|
Hamazaki K, Itomura M, Huan M, Nishizawa
H, Watanabe S, Hamazaki T, Sawazaki S, Terasawa K, Nakajima S,
Terano T, et al: n-3 long-chain FA decrease serum levels of TG and
remnant-like particle-cholesterol in humans. Lipids. 38:353–358.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bays HE, Ballantyne CM, Doyle RT Jr,
Juliano RA and Philip S: Icosapent ethyl: Eicosapentaenoic acid
concentration and triglyceride-lowering effects across clinical
studies. Prostaglandins Other Lipid Mediat. 125:57–64. 2016.
View Article : Google Scholar
|
|
30
|
Bays HE, Ballantyne CM, Kastelein JJ,
Isaacsohn JL, Braeckman RA and Soni PN: Eicosapentaenoic acid ethyl
ester (AMR101) therapy in patients with very high triglyceride
levels (from the Multi-center, plAcebo-controlled, Randomized,
double-blINd, 12-week study with an open-label Extension [MARINE]
trial). Am J Cardiol. 108:682–690. 2011. View Article : Google Scholar
|
|
31
|
Ballantyne CM, Bays HE, Kastelein JJ,
Stein E, Isaacsohn JL, Braeckman RA and Soni PN: Efficacy and
safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in
statin-treated patients with persistent high triglycerides (from
the ANCHOR study). Am J Cardiol. 110:984–992. 2012. View Article : Google Scholar
|
|
32
|
Braeckman RA, Stirtan WG and Soni PN:
Pharmacokinetics of eicosapentaenoic acid in plasma and red blood
cells after multiple oral dosing with icosapent ethyl in healthy
subjects. Clin Pharmacol Drug Dev. 3:101–108. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Silva Jde A, Trindade EB, Fabre ME,
Menegotto VM, Gevaerd S, Buss Zda S and Frode TS: Fish oil
supplement alters markers of inflammatory and nutritional status in
colorectal cancer patients. Nutr Cancer. 64:267–273. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang TM, Hsieh SC, Chen JW and Chiang AN:
Docosahexaenoic acid and eicosapentaenoic acid reduce C-reactive
protein expression and STAT3 activation in IL-6-treated HepG2
cells. Mol Cell Biochem. 377:97–106. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fearon KC, Von Meyenfeldt MF, Moses AG,
Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J,
Barber MD, et al: Effect of a protein and energy dense N-3 fatty
acid enriched oral supplement on loss of weight and lean tissue in
cancer cachexia: A randomised double blind trial. Gut.
52:1479–1486. 2003. View Article : Google Scholar
|
|
36
|
Hanai N, Terada H, Hirakawa H, Suzuki H,
Nishikawa D, Beppu S and Hasegawa Y: Prospective randomized
investigation implementing immunonutritional therapy using a
nutritional supplement with a high blend ratio of ω-3 fatty acids
during the perioperative period for head and neck carcinomas. Jpn J
Clin Oncol. 48:356–361. 2018. View Article : Google Scholar
|
